Abbott Laboratories Highlights Stent Test Results
Save Email Print
Bookmark and Share
Abbott Laboratories Highlights Stent Test Results
Abbott Laboratories says results of a large study put its artery-opening stent on equal footing with a stent made by a competitor in a difficult-to-treat group of patients.
width:200 and height: 120 and picwidth: 200 and pciheight: 120
Font Size:

WASHINGTON (September 23, 2009)--Abbott Laboratories said Tuesday results of a large study put its artery-opening Xience stent on equal footing with competitor Boston Scientific in diabetics, a difficult-to-treat group of patients.

Abbott said there was no difference in safety complications between diabetic patients with a Xience drug-coated stent, compared to Boston Scientific's Taxus Express stent.

Previous results had suggested fewer heart-related problems with Taxus, helping Boston Scientific protect its share of the market for the mesh-wire tubes.

Stents are used to prop open arteries after they have been surgically cleared of fatty plaque.

Boston Scientific complains Abbott compared Xience to Taxus Express, which has been replaced by the more advanced Taxus Liberte.

KWTX.com Features
Double Dollar Deals
Half Price Deals at Central Texas restaurants and businesses. A new deal every Thursday at 7:00am.
Law Line
This free service can help you find answers to your legal questions about personal injury, criminal law, bankruptcy, family law and more.
Army Way
Learn all about the symbols, traditions, and customs of the US Army.
For Your Health
Buddy Check